Predominantly (> 98%), amyloidosis manifests in two subtypes: light chain amyloidosis (AL), involving monoclonal immunoglobulin light chains, and transthyretin amyloidosis (TTR), involving transthyretin protein produced by the liver. Here, TTR is linked to AL amyloidosis.